Rabia Gurses Ozden
CIK 1814883 · Chief Medical Officer · last filed 2025-12-10
Rabia Gurses Ozden is a Chief Medical Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ADVM, was dated Dec 10, 2025. Across all open-market trades the lifetime net is −$38.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.37M
2
13
-$38.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Chief Medical Officer | 0 | $4.36 | $0 | $0 | 7 | 2025-12-10 |
| OCUL | Chief Medical Officer | 153,054 | $8.94 | $1.37M | -$38.9K | 6 | 2024-02-06 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Mixed | −8,125 | $0 | EDGAR |
| 2025-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Mixed | — | $0 | EDGAR |
| 2025-02-27 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +8,125 | $0 | EDGAR |
| 2024-08-06 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-06 | OCUL | Mixed | +72,979 | $30.8K | EDGAR |
| 2024-02-02 | OCUL | Sell (S) | −7,764 | -$38.4K | EDGAR |
| 2023-07-11 | OCUL | Sell (S) | −832 | -$4.1K | EDGAR |
| 2023-06-13 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-08 | OCUL | Sell (S) | −6,416 | -$27.2K | EDGAR |